Vincent Kalut / Photonews via Getty Images Wealthy UK residents won't be able to skip to the front of the line for vaccines, officials told The Financial Times. "Equity is at the heart of our decision to supply only the NHS," a Pfizer manager told the newspaper. On Wednesday, the UK approved the COVID-19 vaccine from Pfizer and BioNTech, marking the first such authorization in a Western country. As of Sunday, the UK had reached deals for about 357 million doses of the vaccine from various companies.